Robot-assisted investigation of sensorimotor control in Parkinson's disease.

Sci Rep

Canadian Surgical Technologies and Advanced Robotics (CSTAR), University of Western Ontario (UWO), London, ON, N6A 5B9, Canada.

Published: March 2023

Sensorimotor control (SMC) is a complex function that involves sensory, cognitive, and motor systems working together to plan, update and execute voluntary movements. Any abnormality in these systems could lead to deficits in SMC, which would negatively impact an individual's ability to execute goal-directed motions. Recent studies have shown that patients diagnosed with Parkinson's disease (PD) have dysfunctions in sensory, motor, and cognitive systems, which could give rise to SMC deficits. However, SMC deficits in PD and how they affect a patient's upper-limb movements have not been well understood. The objective of the study was to investigate SMC deficits in PD and how they affect the planning and correction of upper-limb motions. This was accomplished using a robotic manipulandum equipped with a virtual-reality system. Twenty age-matched healthy controls and fifty-six PD patients (before and after medication) completed an obstacle avoidance task under dynamic conditions (target and obstacles in moving or stationary form, with and without mechanical perturbations). Kinematic information from the robot was used to extract eighteen features that evaluated the SMC functions of the participants. The findings show that the PD patients before medication were 32% slower, reached 16% fewer targets, hit 41% more obstacles, and were 26% less efficient than the control participants, and the difference in these features was statistically significant under dynamic conditions. In addition to the motor deficits, the PD patients also showed deficits in handling high cognitive loads and interpreting sensory cues. Further, the PD patients after medication exhibited worse sensory and cognitive performance than before medication under complex testing conditions. The PD patients also showed deficits in following the computational models leading to poor motor planning.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036530PMC
http://dx.doi.org/10.1038/s41598-023-31299-zDOI Listing

Publication Analysis

Top Keywords

smc deficits
12
patients medication
12
sensorimotor control
8
parkinson's disease
8
sensory cognitive
8
deficits smc
8
deficits affect
8
dynamic conditions
8
patients deficits
8
deficits
7

Similar Publications

Clinical Manifestations.

Alzheimers Dement

December 2024

Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo/SP, Brazil.

Background: Subjective Memory Complaints (SMC) are common with aging and might be associated with objective memory impairment (MI) and with higher risk to develop dementia. This association is understudied in socially and ethnically diverse populations, such as Brazilians.

Method: This study uses the baseline data from the ELSI-Brazil, a representative sample of 9402 Brazilians over 50 years.

View Article and Find Full Text PDF
Article Synopsis
  • * It found that childhood challenging behaviors were significant predictors of later mental health outcomes, overshadowing the impacts of autism and ADHD when challenging behaviors were accounted for.
  • * The research highlights the importance of early intervention strategies addressing challenging behaviors in children, particularly for those with co-occurring conditions like ADHD and autism, to improve adult mental health outcomes.
View Article and Find Full Text PDF

Introduction: Patients with Alzheimer's disease (AD), namely at an initial stage like amnestic cognitive impairment (aMCI), typically present with memory complaints. They also have difficulties regarding self-knowledge about their cognitive deficits. In clinical practice, a formal neuropsychological assessment is often done.

View Article and Find Full Text PDF
Article Synopsis
  • Accumulation of the protein AIMP2 in the brain is linked to cognitive decline in Parkinson's disease (PD), specifically in areas like the temporal lobe and hippocampus.
  • Research involved imaging and experiments with transgenic mice to evaluate how AIMP2 affects neuron health and cognitive function, revealing its toxicity to hippocampal neurons.
  • The study also suggested that AIMP2 could serve as a potential biomarker for PD, as higher levels of this protein were found in the plasma of patients compared to healthy controls.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze brain structure differences in children with ADHD and those with obesity, focusing on brain regions related to cognitive control and reward.
  • It involved 471 children aged 8-12, comparing brain morphology using structural MRI between those with ADHD (some being overweight/obese) and neurotypical controls (some also overweight/obese).
  • Results showed lower surface area in ADHD children and lower cortical thickness in those with obesity, suggesting unique brain changes associated with each condition as well as combined effects of ADHD and obesity on brain regions important for cognitive and motivational processes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!